Biovie Inc
(BIVI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 5 | 9 | 124 | 233 |
| Other current assets | 0 | 0 | 0 | 7 | 0 |
| TOTAL | $N/A | $5 | $9 | $131 | $233 |
| Non-Current Assets | |||||
| Intangibles | 0 | 2,474 | 2,531 | 2,588 | 0 |
| TOTAL | $N/A | $2,474 | $2,531 | $2,588 | $N/A |
| Total Assets | $N/A | $2,478 | $2,540 | $2,719 | $233 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 21 | 18 | 10 | N/A |
| Accounts payable and accrued liabilities | 0 | 506 | 381 | 294 | 1 |
| Accrued Expenses | N/A | 625 | 562 | 500 | 444 |
| TOTAL | $N/A | $1,151 | $961 | $803 | $445 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $N/A | $1,151 | $961 | $803 | $445 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 877 | 872 | N/A | 872 |
| Common Shares | N/A | 9 | 9 | 9 | 9 |
| Retained earnings | N/A | -1,714 | -1,356 | -1,004 | -735 |
| TOTAL | $N/A | $1,327 | $1,578 | $1,916 | $-212 |
| Total Liabilities And Equity | $0 | $2,478 | $2,540 | $2,719 | $233 |